Effects of Capecitabine and Celecoxib in Experimental Pancreatic Cancer

Publisher： Karger

E-ISSN： 1424-3911|10|5|641-647

ISSN： 1424-3903

Source： Pancreatology, Vol.10, Iss.5, 2010-11, pp. : 641-647

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Capecitabine and Celecoxib as Second-Line Treatment of Advanced Pancreatic and Biliary Tract Cancers

By  

Oncology, Vol. 76, Iss. 4, 2009-02 ,pp. : 254-261

Karger

Access to resources Recommend Favorite

Effects of Octreotide on Liver Metastasis and Intrametastatic Lipid Peroxidation in Experimental Pancreatic Cancer

By  

Oncology, Vol. 60, Iss. 3, 2001-04 ,pp. : 282-288

Karger

Access to resources Recommend Favorite

Oral Capecitabine in Gemcitabine-Pretreated Patients with Advanced Pancreatic Cancer

By  

Oncology, Vol. 73, Iss. 3-4, 2008-04 ,pp. : 221-227

Karger

Access to resources Recommend Favorite

Effectiveness and Tolerability of Maintenance Capecitabine Administrated to Patients with Metastatic Pancreatic Cancer Treated with First-Line FOLFIRINOX

By  

Oncology, Vol. 90, Iss. 5, 2016-04 ,pp. : 261-266

Karger

Access to resources Recommend Favorite

Capecitabine in colorectal cancer

By Braun Michael S   Twelves Chris J  

Therapy, Vol. 6, Iss. 2, 2009-03 ,pp. : 239-248

Future Medicine

Access to resources Recommend Favorite